Integrated Diagnostics Holdings plc (IDGXF)

Market Cap	315.37M +69.5%
Revenue (ttm)	154.53M +42.9%
Net Income	27.53M +55.5%
EPS	0.05 +55.5%
Shares Out	n/a
PE Ratio	11.46
Forward PE	11.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	900
Average Volume	2,224
Open	0.6400
Previous Close	0.6000
Day's Range	0.6400 - 0.6400
52-Week Range	0.2830 - 0.6983
Beta	0.28
RSI	60.19
Earnings Date	Apr 8, 2026

About IDGXF

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDGXF

Financial Performance

In 2024, IDGXF's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP